Brandstetter, Lilly Sophia http://orcid.org/0000-0003-0158-5402
Jírů-Hillmann, Steffi http://orcid.org/0000-0002-1275-5967
Störk, Stefan http://orcid.org/0000-0002-1771-7249
Heuschmann, Peter Ulrich http://orcid.org/0000-0002-2681-3515
Wöckel, Achim http://orcid.org/0000-0002-6767-9666
Reese, Jens-Peter http://orcid.org/0000-0003-3545-2552
Funding for this research was provided by:
Bayerische Staatsministerium für Gesundheit und Pflege (PBN-MGP-2010-0004-DigiOnko, PBN-MGP-2010-0004-DigiOnko, PBN-MGP-2010-0004-DigiOnko)
Julius-Maximilians-Universität Würzburg
Article History
Accepted: 11 February 2024
First Online: 7 March 2024
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL. This study was supported as a part of the project BRE-BY-MED ‘Breast Cancer Care in Bavaria for Patients with Metastatic Disease’ (DRKS00026601), which is integrated in the mantle project digiOnko ‘Integrative Concept for personalised precision medicine in prevention, screening, therapy and recurrence prevention on the example of breast cancer’ [CitationRef removed], funded by the Bavarian State Ministry for Health and Care (project grant number PBN-MGP-2010-0004-DigiOnko).
: L.B. and S.J.H. report no conflict of interest. St.S. received speaker honoraria as well as reimbursement of travel costs from AstraZeneca, Bayer, Boehringer-Ingelheim, Sanofi, Servier; received financial support for carrying out clinical studies from AstraZeneca, Bayer, Boehringer-Ingelheim, Novartis, NovoNordisk, Pfizer, Sanofi; received personal payments for Data Safety Monitoring Board or Advisory Board activities from AstraZeneca, Bayer, Boehringer-Ingelheim, NovoNordisk, Sanofi, Servier; unpaid Board Membership in the Writing Group National Guideline Heart Failure Guideline Germany, ESC-HFA Committee of the National Heart Failure Societies, ESC-HFA Patient Website: Heartfailurematters.org, outside the submitted work. P.U.H. reports research grants from the German Ministry of Research and Education, Federal Joint Committee (G-BA) within the Innovationfond, European Union, German Parkinson Society, University Hospital Würzburg, German Heart Foundation, German Research Foundation, Bavarian State, German Cancer Aid, Charité – Universitätsmedizin Berlin (within Mondafis; supported by an unrestricted research grant to the Charité from Bayer), University Göttingen (within FIND-AF randomized; supported by an unrestricted research grant to the University Göttingen from Boehringer-Ingelheim), University Hospital Heidelberg (within RASUNOA-prime; supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer, BMS, Boehringer-Ingelheim, Daiichi Sankyo); participation on DSMB in publicly funded studies (by German Research Foundation, German Ministry of Research, Foundations), outside the submitted work. AW reports research grants from the Federal Joint Committee (G-BA) within the Innovationfond, outside the submitted work, consulting fees received from AstraZeneca, Lilly, Novartis, Pfizer, Roche, MSD, Pierre Fabre, Seagen, Exact Sciences, Gilead, Dajichi Sanko; speaker honoraria received from Aurikamed and Onkowissen; support for attending meetings and/or travel received from Pfizer, Dajichi Sanko; leadership or fiduciary role in AGO, S3-Guideline Breast Cancer, German Society of Breast Cancer (BGGF). J.P.R. reports research grants from the German Ministry of Research and Education, Bavarian State (ministry for science and the arts), Federal Joint Committee (G-BA) within the Innovationfond, German Center for Lung Research; payment for expert testimony from the German Ministry of Health (BMG); payment for EBM Training Lecture by the Landesaerztekammer Hessen, outside the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated during the current study.
: Not applicable.
: All authors contributed to the conception and design of the work. L.B. and S.J.H. contributed to material preparation, data collection and analysis. The first draft of the manuscript was written by L.B. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.